NUVAGEN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-11-17 for NUVAGEN manufactured by Ruspak Corporation.

Event Text Entries

[93434900] This initial non-serious spontaneous report, which originated from the united states, was received on 15-sep-2017. Information has been received from a consumer concerning a female patient on unspecified age who was using nuvagen collagen powder. The patient's medical history and concomitant medication information was not provided. From an unspecified date the patient was using nuvagen collagen powder (1 gm packet). Batch number and expiry date was not provided. On (b)(6) 2017, while applying nuvagen collagen powder, the subject experienced pain at wound site. It was reported that the patient had wounds between her toes and the wounds were severe. When the consumer applied collagen powder to her mother's wounds, the patient could not tolerate as she had pain at wound site. The patient received alginate with silver per order from doctor. Action taken with nuvagen collagen powder was not reported. Outcome of the event 'pain at wound site' was not reported. The reporter stated that due to the severity of the wounds, any dressing would have caused the pain at the wound site and that it was not actually related to the collagen powder itself. A product quality complaint was raised and complaint sample was not available. No further information was provided.
Patient Sequence No: 1, Text Type: N, H10


[93434901] This initial non-serious spontaneous report, which originated from the united states, was received on 15-sep-2017. Information has been received from a consumer concerning a female patient on unspecified age who was using nuvagen collagen powder. The patient's medical history and concomitant medication information was not provided. From an unspecified date the patient was using nuvagen collagen powder (1 gm packet). Batch number and expiry date was not provided. On (b)(6) 2017, while applying nuvagen collagen powder, the subject experienced pain at wound site. It was reported that the patient had wounds between her toes and the wounds were severe. When the consumer applied collagen powder to her mother's wounds, the patient could not tolerate as she had pain at wound site. The patient received alginate with silver per order from doctor. Action taken with nuvagen collagen powder was not reported. Outcome of the event 'pain at wound site' was not reported. The reporter stated that due to the severity of the wounds, any dressing would have caused the pain at the wound site and that it was not actually related to the collagen powder itself. A product quality complaint was raised and complaint sample was not available. No further information was provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1000526113-2017-70002
MDR Report Key7042070
Date Received2017-11-17
Date of Report2017-12-22
Date of Event2017-09-14
Report Date2017-10-20
Date Reported to Mfgr2017-10-20
Date Mfgr Received2017-10-20
Date Added to Maude2017-11-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer Street6911 BRYAN DAIRY ROAD SUITE # 210
Manufacturer CityLARGO FL 33777
Manufacturer CountryUS
Manufacturer Postal33777
Manufacturer G11. BELCHER PHARMACEUTICALS, LLC (PRODUCT HOLDER)
Manufacturer Street2. RUSPAK CORPORATION (MANUFACTURER)
Manufacturer CountryUS
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameNUVAGEN
Generic NameNUVAGEN
Product CodeKOZ
Date Received2017-11-17
Lot Number150216, 150216A AND 150506
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerRUSPAK CORPORATION
Manufacturer Address6911 BRYAN DAIRY ROAD 5 MANHATTAN STREET, P.O.BOX 29 LYONS. TEL: (315) 946-9777 NY 14489 US 14489


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2017-11-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.